Morphological and Crystalline Transitions in Monohydrous and Anhydrous Aripiprazole for a Long-Acting Injectable Suspension
Authors:
- 1 August 2016
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 18 (4) , 1270-1276
Abstract
Many formulation and manufacturing processes can lead to morphological and crystalline transitions in many polycrystalline drugs, changing the properties of active pharmaceutical ingredients (APIs)...Keywords
This publication has 20 references indexed in Scilit:
- Aripiprazole once-monthly long-acting injectable for the treatment of schizophreniaExpert Opinion on Pharmacotherapy, 2016
- Studies of phase transitions in the aripiprazole solid dosage formJournal of Pharmaceutical and Biomedical Analysis, 2016
- A review of aripiprazole long-acting injectionCurrent Medical Research and Opinion, 2015
- Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxilExpert Review of Clinical Pharmacology, 2015
- Flash Nanoprecipitation: Prediction and Enhancement of Particle Stability via Drug StructureMolecular Pharmaceutics, 2014
- Evaluating the Roles of Conformational Strain and Cohesive Binding in Crystalline Polymorphs of AripiprazoleCrystal Growth & Design, 2013
- Stability of Solvates and Packing Systematics of Nine Crystal Forms of the Antipsychotic Drug AripiprazoleCrystal Growth & Design, 2008
- Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case StudyPharmaceutical Research, 2008
- Nanosizing — Oral formulation development and biopharmaceutical evaluationAdvanced Drug Delivery Reviews, 2007
- Aggregation-Based Crystal Growth and Microstructure Development in Natural Iron Oxyhydroxide Biomineralization ProductsScience, 2000